GPP

Great Point Partners Portfolio holdings

AUM $154M
This Quarter Return
+12.46%
1 Year Return
-2.36%
3 Year Return
+169.3%
5 Year Return
+292.82%
10 Year Return
+3,519.88%
AUM
$447M
AUM Growth
+$447M
Cap. Flow
+$20M
Cap. Flow %
4.46%
Top 10 Hldgs %
53.82%
Holding
50
New
14
Increased
13
Reduced
3
Closed
14

Top Buys

1
GLPG icon
Galapagos
GLPG
$16.5M
2
RLMD icon
Relmada Therapeutics
RLMD
$16.2M
3
SRPT icon
Sarepta Therapeutics
SRPT
$13.1M
4
BCYC
Bicycle Therapeutics
BCYC
$12.2M
5
RNA icon
Avidity Biosciences
RNA
$11.9M

Top Sells

1
KDMN
Kadmon Holdings, Inc.
KDMN
$29.4M
2
DRNA
Dicerna Pharmaceuticals, Inc.
DRNA
$16.1M
3
UTHR icon
United Therapeutics
UTHR
$16M
4
BIIB icon
Biogen
BIIB
$13.4M
5
SAGE
Sage Therapeutics
SAGE
$11.9M

Sector Composition

1 Healthcare 99.67%
2 Real Estate 0.33%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
KNSA icon
26
Kiniksa Pharmaceuticals
KNSA
$2.63B
$6.32M 1.4%
536,738
+56,738
+12% +$668K
PVLA
27
Palvella Therapeutics, Inc. Common Stock
PVLA
$592M
$5.86M 1.3%
+1,550,000
New +$5.86M
KALV icon
28
KalVista Pharmaceuticals
KALV
$713M
$5.45M 1.21%
+411,937
New +$5.45M
DNTH icon
29
Dianthus Therapeutics
DNTH
$781M
$5.18M 1.15%
1,170,000
– –
PYXS icon
30
Pyxis Oncology
PYXS
$91.2M
$4.39M 0.97%
+400,000
New +$4.39M
SYRE icon
31
Spyre Therapeutics
SYRE
$1.02B
$4.32M 0.96%
910,251
+10,251
+1% +$48.7K
ABUS icon
32
Arbutus Biopharma
ABUS
$753M
$2.6M 0.58%
+668,907
New +$2.6M
CABA icon
33
Cabaletta Bio
CABA
$144M
$1.79M 0.4%
+472,433
New +$1.79M
RFL icon
34
Rafael Holdings
RFL
$53.4M
$1.46M 0.32%
285,714
– –
PNT
35
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
$1.07M 0.24%
+190,520
New +$1.07M
OLMA icon
36
Olema Pharmaceuticals
OLMA
$432M
– –
-329,086
Closed -$9.07M
APLS icon
37
Apellis Pharmaceuticals
APLS
$3.51B
– –
0
– –
BIIB icon
38
Biogen
BIIB
$20.8B
– –
-47,500
Closed -$13.4M
COLL icon
39
Collegium Pharmaceutical
COLL
$1.25B
– –
-121,342
Closed -$2.4M
CTMX icon
40
CytomX Therapeutics
CTMX
$350M
– –
-1,500,000
Closed -$7.64M
FOLD icon
41
Amicus Therapeutics
FOLD
$2.42B
– –
-249,000
Closed -$2.38M
IFRX icon
42
InflaRx
IFRX
$117M
– –
-551,918
Closed -$1.43M
NKTR icon
43
Nektar Therapeutics
NKTR
$543M
– –
-504,691
Closed -$9.06M
PBYI icon
44
Puma Biotechnology
PBYI
$258M
– –
-1,300,000
Closed -$9.11M
PHAT icon
45
Phathom Pharmaceuticals
PHAT
$843M
– –
-220,863
Closed -$7.09M
RPTX icon
46
Repare Therapeutics
RPTX
$73.9M
– –
-93,137
Closed -$2.44M
SAGE
47
DELISTED
Sage Therapeutics
SAGE
– –
-269,010
Closed -$11.9M
UTHR icon
48
United Therapeutics
UTHR
$17.7B
– –
-86,667
Closed -$16M
DRNA
49
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
– –
-799,999
Closed -$16.1M
KDMN
50
DELISTED
Kadmon Holdings, Inc.
KDMN
– –
-3,375,000
Closed -$29.4M
1
2